Syncom Formulations (India)

Syncom Formulations (India) EV/OCF

The EV/OCF (Enterprise Value to Operating Cash Flow) of Syncom Formulations (India) (SYNCOMF.NS) as of Oct 17, 2026 is 17.78. In the previous year, EV/OCF (Enterprise Value to Operating Cash Flow) was 44.29 — a change of -59.86% (lower).

EV/OCF

17.78

YoY

-59.86%

Last updated:

EV/OCF (Enterprise Value to Operating Cash Flow) of Syncom Formulations (India) is 2026 17.78 . EV/OCF (Enterprise Value to Operating Cash Flow) of Syncom Formulations (India) was 2025 44.29 . It decreases by -59.86% lower compared to the previous year.

The Syncom Formulations (India) EV/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/OCF
Date
EV/OCF
Jan 1, 2019
259.70 INR
Jan 1, 2020
-2,208.96 INR
Jan 1, 2021
-557.79 INR
Jan 1, 2022
69.87 INR
Jan 1, 2023
107.85 INR
Jan 1, 2024
-178.61 INR
Jan 1, 2025
44.29 INR
Jan 1, 2026
17.78 INR
The Syncom Formulations (India) EV/OCF history
YEAREV/OCFYoY
17.78-59.86%
44.29-124.80%
-178.61-265.61%
107.85+54.37%
69.87-112.53%
-557.79-74.75%
-2,208.96-950.60%
259.70-136.79%
-705.97-965.30%
81.59+75.59%
46.46-99.23%
6,009.65+3,507.10%
166.61—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Syncom Formulations (India) Stock analysis

What does Syncom Formulations (India) do? Syncom Formulations (India) Ltd., headquartered in Indore, Madhya Pradesh, is a pharmaceutical company operating in the Health Care sector. It develops, manufactures, and markets a wide range of healthcare products including tablets, capsules, injections, ophthalmic preparations, and nutritional formulations. The company employs 799 full-time staff and serves domestic markets with product lines such as Cratus Life Care and Cratus Right Nutrition. Its portfolio includes antibiotics like Ciprofloxacin and Ceftriaxone for various medical applications. Syncom Formulations (India) is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Syncom Formulations (India) stock

EV/OCF (Enterprise Value to Operating Cash Flow) of Syncom Formulations (India) is 17.78 in 2026.

EV/OCF (Enterprise Value to Operating Cash Flow) of Syncom Formulations (India) changed from 44.29 to 17.78, representing a -59.86% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/OCF (Enterprise Value to Operating Cash Flow) Syncom Formulations (India) since 2006 – with annual values, charts, and detailed analysis.

EV/OCF compares enterprise value to operating cash flow, measuring how much investors pay per unit of cash generated from operations.

To evaluate EV/OCF (Enterprise Value to Operating Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/OCF (Enterprise Value to Operating Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/OCF (Enterprise Value to Operating Cash Flow)'s Syncom Formulations (India) with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Syncom Formulations (India)

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Syncom Formulations (India)